Gefitinib and Docetaxel in Treating Patients With Advanced Solid Tumors
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Gefitinib may stop the growth of tumor cells by blocking the enzymes necessary for
their growth. Drugs used in chemotherapy such as docetaxel work in different ways to stop
tumor cells from dividing so they stop growing or die. Giving gefitinib with docetaxel may
kill more tumor cells.
PURPOSE: This phase I trial is studying the side effects and best dose of gefitinib when
given with docetaxel in treating patients with advanced solid tumors.